We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA, EMEA: Drugmakers Can Group Changes to Marketing Authorizations
MHRA, EMEA: Drugmakers Can Group Changes to Marketing Authorizations
December 17, 2009
Drugmakers seeking to amend a marketing authorization with the European Medicines Agency (EMEA) or the UK’s Medicines and Healthcare products Regulatory
Agency (MHRA) now can group proposed changes into a single application.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor